A 6-year-old girl is one of more than 80 people worldwide who has finally received a diagnosis of a new condition following ...

Once belonging only in children’s tales, the perception that you’re much larger or smaller than the world around you is a genuine brain-related condition.

For seizures that cause falls, a protective helmet helps prevent injury. A good seizure helmet should provide safety and ...

To learn more about our editorial approach, explore The Direct Message methodology. Eight-year-old Freddie Truelove used to have hundreds of seizures a day. Now he has a couple a week — and his mother ...

A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, the findings of a UCL ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91 ...

TREATABLE ARE DEFINITELY MAKING A COMEBACK. WE HAVE A NEW WARNING TONIGHT ABOUT YOUNG CHILDREN AND FLU SHOTS. THE FDA IS SAYING NOW THAT IT WANTS MANUFACTURERS TO ADD THE RISK FOR SEIZURES TO THAT ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA wants seizure risk added to flu vaccine labels for young children. Dr. Todd Ellerin breaks down the studies, how serious ...

Bright Minds Biosciences (DRUG) added ~10% in the premarket on Tuesday after the company said that its lead asset, BMB-101, succeeded in a mid-stage trial for adults with Absence Seizures and ...

Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012 DEE: 63.3% median reduction in major motor seizures REM sleep improvement in patients with Absence Seizures: mean 90% ...

Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a jolt and setting up future registrational trials for the serotonin receptor ...

(RTTNews) - Bright Minds Biosciences Inc. (DRUG), a clinical-stage biotechnology company, announced that it will host a conference call and live webcast at 8:00 AM ET on January 6, 2026, to report ...